WallStreetZenWallStreetZen

AnalystsSean Lavin
Sean Lavin's Stock Forecasts

Analyst Ranking
Top 22%
#1012 out of 4560 analysts
Average Return
+19.35%
Win Rate
67%10 out of 15
Risk vs Reward
Poor
Good

Sean Lavin's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Exact Sciences CorpEXAS
+129.18%$40.40$92.59
2018-04-03 -
2019-04-03
Strong Buy
Neogenomics IncNEO
+127.96%$9.05$20.63
2018-04-16 -
2019-04-16
Buy
Tactile Systems Technology IncTCMD
+84.31%$25.43$46.87
2017-11-09 -
2018-06-04
Strong Buy
Boston Scientific CorpBSX
+43.34%$26.28$37.67
2017-11-30 -
2018-11-30
Strong Buy
Masimo CorpMASI
+31.17%$85.54$112.20
2017-08-14 -
2018-08-14
Strong Buy

Sean Lavin Analyst Color

Get additional color on Sean Lavin's coverage of popular stocks

Sean Lavin's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Hologic IncHOLX
1HoldN/AN/ADowngrades
2 years ago
Insulet CorpPODD
4Strong Buy$320.00N/AUpgrades
2 years ago
Medtronic PLCMDT
1HoldN/AN/ADowngrades
2 years ago
Masimo CorpMASI
2HoldN/AN/ADowngrades
5 years ago
Irhythm Technologies IncIRTC
2Strong Buy$80.00N/AUpgrades
5 years ago
Atricure IncATRC
2Strong Buy$35.00N/AUpgrades
5 years ago
Helius Medical Technologies IncHSDT
2Strong Buy$24,500.00N/AUpgrades
5 years ago
Abiomed IncABMD
2Strong Buy$450.00N/AUpgrades
5 years ago
Tactile Systems Technology IncTCMD
3HoldN/AN/ADowngrades
6 years ago
Neogenomics IncNEO
2BuyN/AN/AUpgrades
6 years ago
Exact Sciences CorpEXAS
2Strong BuyN/AN/AUpgrades
6 years ago
Abbott LaboratoriesABT
1HoldN/AN/ADowngrades
6 years ago
Boston Scientific CorpBSX
1Strong BuyN/AN/AUpgrades
6 years ago
Varian Medical Systems IncVAR
2HoldN/AN/ADowngrades
7 years ago
Edwards Lifesciences CorpEW
2Strong Buy$43.33N/AMaintains
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.